Minimizing immunogenicity of the SDR-grafted humanized antibody CC49 by genetic manipulation of the framework residues

Author： Gonzales N.R. Padlan E.A. De Pascalis R. Schuck P. Schlom J. Kashmiri S.V.S.

Publisher： Elsevier

ISSN： 0161-5890

Source： Molecular Immunology, Vol.40, Iss.6, 2003-10, pp. : 337-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Vitro and In Vivo Evaluation of a Humanized Anti-APRIL Antibody

Current Molecular Medicine, Vol. 13, Iss. 3, 2013-03 ,pp. : 464-465

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Recalcitrant Plaque Psoriasis with a Humanized Non-depleting Antibody to CD4

By Bachelez H. Flageul B. Dubertret L. Fraitag S. Grossman R. Brousse N. Poisson D. Knowles R.W. Wacholtz M.C. Haverty T.P. Chatenoud L. Bach J.F.

Journal of Autoimmunity, Vol. 11, Iss. 1, 1998-02 ,pp. : 53-62

Academic Press

Access to resources Recommend Favorite

Humanized, Nonmitogenic OKT3 Antibody, huOKT3 (Ala-Ala): Initial Clinical Experience

By Woodle E.S. Bluestone J.A. Zivin R.A. Jolliffe L.K. Auger J. Xu D. Thistlethwaite J.R.

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1369-1370

Elsevier

Access to resources Recommend Favorite

Placebo-Controlled Study of a Humanized Anti-TAC Monoclonal Antibody in Dual Therapy for Prevention of Acute Rejection After Renal Transplantation

By Charpentier B. Thervet E.

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1331-1332

Elsevier

Access to resources Recommend Favorite

Human B Cell Development and Antibody Production in Humanized NOD/SCID/IL-2Rγ^null (NSG) Mice Conditioned by Busulfan

By Choi Bongkum Chun Eunyoung Kim Miyoung Kim Seong-Tae Yoon Keejung Lee Ki-Young Kim Sung

Journal of Clinical Immunology, Vol. 31, Iss. 2, 2011-04 ,pp. : 253-264

Springer Publishing Company

Access to resources Recommend Favorite